2020 Kia Telluride Sx on 2040-cars

Auto blog

Kia K900 confirmed for LA Auto Show debut

Although there has been plenty of news about the Kia K9/Quoris over the past year and a half, we've yet to hear anything from Kia regarding the US fate of its flagship, rear-wheel-drive sedan. That changes today, however, as Kia has confirmed the recent rumor that the car would be renamed K900 for the US market, and that the luxurious sedan would debut next month at the LA Auto Show and go on sale next year.
Along with the announcement, Kia also released its first image of the US-spec K900, and, not surprisingly, this profile shot is identical to what we've seen in images for the Korean-market K9 and globally named Quoris (click above to enlarge). Unlike the closely related Hyundai Equus, the Kia K900 will offer customers the option of V6 or V8 engines, but it will be fitted with just as many luxurious amenities as its Hyundai counterpart.
We'll probably have to wait until closer to the K900's on-sale date for any official word on pricing, but last we heard, it will be priced between $50,000 and $70,000 - a significant step up from the current top-drawer model, the Kia Cadenza. Scroll down for the brief press release, and check back in a few weeks for live coverage of this car's debut.

Hyundai and Kia recalling 1.6M more models for faulty brake switch

In what is likely the largest recall campaign for Hyundai and Kia, the National Highway Traffic Safety Administration has announced a recall of more than 1.6 million models due to a faulty brake switch. This is in addition to almost 700,000 Hyundai and Kia models recalled for the same problem back in 2009.
In more than 620,000 Kia models and 1 million Hyundai products for the 2007 through 2011 model years, the brake switch could malfunction causing the brake lights to not illuminate, which could lead to accident. Other possible issues with a faulty switch include the cruise control not cancelling with the brake pedal, the push-button starter not working properly and the shift interlock not disengaging causing the transmission to be stuck in Park. To fix the problem, the brake lights switch will be replaced.
Due to the large number of units being recalled, both automakers are issuing a notice by next month with parts not expected to be ready until June. The full list of affected vehicles and the NHTSA press releases are posted below.

Hyundai Kia asked to pay $28.9M in patent infringement case

After years of litigation, Hyundai and Kia have lost their hybrid technology patent infringement case against Paice LLC. The jury ordered the South Korean automakers to pay $28.9 million, but according to Bloomberg, because the violation was allegedly intentional, the judge could triple that amount. The automakers have announced plans to appeal the ruling. Paice's patent dates from 1994 on a piece of tech called the Hyperdrive, and it was a way to seamlessly switch between power from an electric motor and an internal combustion engine. This lawsuit was first filed in 2012 and covered the systems in the Hyundai Sonata Hybrid and Kia Optima Hybrid. According to Bloomberg, the companies tried to argue that the patent was no longer valid, but the strategy failed. "Hyundai strongly believes its position and will appeal any remaining adverse findings to the Federal Circuit," the company said in a statement to Autoblog. Paice is certainly no stranger to litigating over the Hyperdrive patent, though. It and Toyota had a similar court battle that lasted years. Eventually, there was a settlement, and the result was Paice getting royalties for each hybrid that the Japanese automaker sold. Similarly, there's a lawsuit pending against Ford over tech in the C-Max, Fusion, and Lincoln MKZ. Hyundai Statement: Hyundai believes that the verdict returned by the jury today in the matter of Paice v. Hyundai Motor Company et al., is not supported by the evidence. Accordingly, Hyundai has requested that the presiding judge enter a judgment in its favor notwithstanding the verdict. Hyundai strongly believes its position and will appeal any remaining adverse findings to the Federal Circuit.